Globally, oral cancer is the sixth most common type of cancer with India contributing to almost one-third of the total burden and the second country having the highest number of oral cancer cases.
In this video, an oral cancer patient shares his journey to recovery with Denvax treatment.
#oralcancer #cancersurvivor #denvax
Denvax Cancer Immunotherapy is a Cell-based cancer treatment for solid tumors in any stage. The treatment is safe, and effective against most cancers. It works to prevent relapse in cancer. It also works as palliative therapy and prolonging life. Denvax is adjuvant/ additional treatment plan.
Dr. Jamal A. Khan and Dr. Sharmin Yaqin have co-founded Denvax Cancer Immunotherapy. Together they have been in clinical practice of Dendritic cell therapy (Denvax) exclusively for the past 17 years. They pioneered the research in customized Immunotherapy in India in the year 2004.
The Denvax clinics are owned and managed by Dr. Jamal and Dr. Sharmin. They comprise a team of doctors and paramedical staff who are engaged in administering of this customized treatment protocol.
They can be reached at contact@denvaxindia.com
Get in touch for you cancer care:
Toll Free: 1800 123 1123, +91-11410 60168, +91-93118 08420, +91-96251 50164
Visit our website to understand more: www.denvaxindia.com
0 Comments